UK markets close in 41 minutes

Bausch Health Companies Inc. (BHC)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
29.24-0.55 (-1.85%)
As of 10:48AM EDT. Market open.
Currency in USD

Valuation measures

Market cap (intra-day) 510.53B
Enterprise value 333.85B
Trailing P/E N/A
Forward P/E 16.14
PEG ratio (5-yr expected) 11.20
Price/sales (ttm)1.31
Price/book (mrq)N/A
Enterprise value/revenue 34.21
Enterprise value/EBITDA 710.66

Trading information

Stock price history

Beta (5Y monthly) 1.73
52-week change 352.15%
S&P500 52-week change 336.29%
52-week high 334.80
52-week low 314.86
50-day moving average 330.44
200-day moving average 328.24

Share statistics

Avg vol (3-month) 32.81M
Avg vol (10-day) 31.96M
Shares outstanding 5358.4M
Implied shares outstanding 6N/A
Float 304.42M
% held by insiders 12.94%
% held by institutions 171.70%
Shares short (27 May 2021) 420.07M
Short ratio (27 May 2021) 46.25
Short % of float (27 May 2021) 46.41%
Short % of shares outstanding (27 May 2021) 45.60%
Shares short (prior month 29 Apr 2021) 416.09M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 409 Nov 2010
Last split factor 22:1
Last split date 315 Oct 2000

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Mar 2021

Profitability

Profit margin -12.66%
Operating margin (ttm)17.77%

Management effectiveness

Return on assets (ttm)2.88%
Return on equity (ttm)-304.51%

Income statement

Revenue (ttm)8.04B
Revenue per share (ttm)22.60
Quarterly revenue growth (yoy)0.70%
Gross profit (ttm)5.78B
EBITDA 3.18B
Net income avi to common (ttm)-1.02B
Diluted EPS (ttm)-2.86
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)679M
Total cash per share (mrq)1.89
Total debt (mrq)23.74B
Total debt/equity (mrq)N/A
Current ratio (mrq)1.10
Book value per share (mrq)-0.55

Cash flow statement

Operating cash flow (ttm)1.29B
Levered free cash flow (ttm)1.46B